Accuray announces approval of the tomo® c radiation treatment delivery system by china's national medical products administration

Madison, wis. , oct. 3, 2023 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that the registration dossier for the cnnc-accuray joint venture tomo® c radiation therapy system for the type b market has been approved by the chinese national medical products administration (nmpa).
ARAY Ratings Summary
ARAY Quant Ranking